Mesa Labs launches restructuring plan to cut annualized operating costs by about $9.3 million

• Mesa Laboratories launched a restructuring and savings plan targeting about $9.3 million in annualized operating cost cuts.
• Roughly $4.3 million of savings will be reinvested for growth, implying a net annualized cost reduction of about $5 million.
• Plan includes eliminating about 40 roles, about 6% of headcount, with limited impact on manufacturing operations.
• Cost cuts concentrate in Clinical Genomics, which will be managed for profitability with lower revenue expected.
• Program includes exiting the Hamburg facility when its lease ends in February 2027; actions largely complete by fiscal 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mesa Laboratories Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-032499), on October 13, 2026, and is solely responsible for the information contained therein.